Search research articles
Contact Us
Filters
Showing results (71-80 of 99) with videos related to
Page
of 10
Sort By:
Molecular Cancer Therapeutics
|
October 17, 2018
Enhanced Antitumor Efficacy of Oncolytic Adenovirus-loaded Menstrual Blood-derived Mesenchymal Stem Cells in Combination with Peripheral Blood Mononuclear Cells
Rafael Moreno, Carlos Alberto Fajardo, Marti Farrera-Sal, et al.
Neoplasia (New York, N.Y.)
|
February 22, 2005
Comparative effect of oncolytic adenoviruses with E1A-55 kDa or E1B-55 kDa deletions in malignant gliomas
Hong Jiang, Candelaria Gomez-Manzano, Ramon Alemany, et al.
Cancer Research
|
September 7, 2007
ICOVIR-5 shows E2F1 addiction and potent antiglioma effect in vivo
Marta M Alonso, Manel Cascallo, Candelaria Gomez-Manzano, et al.
Human Gene Therapy
|
June 20, 2012
Combined fiber modifications both to target α(v)β(6) and detarget the coxsackievirus-adenovirus receptor improve virus toxicity profiles in vivo but fail to improve antitumoral efficacy relative to adenovirus serotype 5
Lynda Coughlan, Sabari Vallath, Alena Gros, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 1, 2020
Modification of Extracellular Matrix Enhances Oncolytic Adenovirus Immunotherapy in Glioblastoma
Juri Kiyokawa, Yoichiro Kawamura, Shanawaz M Ghouse, et al.
Human Gene Therapy
|
September 21, 2018
A Phase 1 Trial of Oncolytic Adenovirus ICOVIR-5 Administered Intravenously to Cutaneous and Uveal Melanoma Patients
Margarita García, Rafael Moreno, Marta Gil-Martin, et al.
Scientific Reports
|
May 25, 2021
Predicting MHC I restricted T cell epitopes in mice with NAP-CNB, a novel online tool
Carlos Wert-Carvajal, Rubén Sánchez-García, José R Macías, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 24, 2006
Delta-24 increases the expression and activity of topoisomerase I and enhances the antiglioma effect of irinotecan
Candelaria Gomez-Manzano, Marta M Alonso, W K Alfred Yung, et al.
International Journal of Molecular Sciences
|
July 14, 2023
SWI/SNF Complex Alterations in Tumors with Rhabdoid Features: Novel Therapeutic Approaches and Opportunities for Adoptive Cell Therapy
Juan José Soto-Castillo, Lucía Llavata-Marti, Roser Fort-Culillas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 22, 2004
Conditionally replicative adenovirus with tropism expanded towards integrins inhibits osteosarcoma tumor growth in vitro and in vivo
Adhiambo M Witlox, Victor W Van Beusechem, Bonnie Molenaar, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 99) with videos related to
Sort By:
Page
of 10
Molecular Cancer Therapeutics
|
October 17, 2018
Enhanced Antitumor Efficacy of Oncolytic Adenovirus-loaded Menstrual Blood-derived Mesenchymal Stem Cells in Combination with Peripheral Blood Mononuclear Cells
Rafael Moreno, Carlos Alberto Fajardo, Marti Farrera-Sal, et al.
Neoplasia (New York, N.Y.)
|
February 22, 2005
Comparative effect of oncolytic adenoviruses with E1A-55 kDa or E1B-55 kDa deletions in malignant gliomas
Hong Jiang, Candelaria Gomez-Manzano, Ramon Alemany, et al.
Cancer Research
|
September 7, 2007
ICOVIR-5 shows E2F1 addiction and potent antiglioma effect in vivo
Marta M Alonso, Manel Cascallo, Candelaria Gomez-Manzano, et al.
Human Gene Therapy
|
June 20, 2012
Combined fiber modifications both to target α(v)β(6) and detarget the coxsackievirus-adenovirus receptor improve virus toxicity profiles in vivo but fail to improve antitumoral efficacy relative to adenovirus serotype 5
Lynda Coughlan, Sabari Vallath, Alena Gros, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 1, 2020
Modification of Extracellular Matrix Enhances Oncolytic Adenovirus Immunotherapy in Glioblastoma
Juri Kiyokawa, Yoichiro Kawamura, Shanawaz M Ghouse, et al.
Human Gene Therapy
|
September 21, 2018
A Phase 1 Trial of Oncolytic Adenovirus ICOVIR-5 Administered Intravenously to Cutaneous and Uveal Melanoma Patients
Margarita García, Rafael Moreno, Marta Gil-Martin, et al.
Scientific Reports
|
May 25, 2021
Predicting MHC I restricted T cell epitopes in mice with NAP-CNB, a novel online tool
Carlos Wert-Carvajal, Rubén Sánchez-García, José R Macías, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 24, 2006
Delta-24 increases the expression and activity of topoisomerase I and enhances the antiglioma effect of irinotecan
Candelaria Gomez-Manzano, Marta M Alonso, W K Alfred Yung, et al.
International Journal of Molecular Sciences
|
July 14, 2023
SWI/SNF Complex Alterations in Tumors with Rhabdoid Features: Novel Therapeutic Approaches and Opportunities for Adoptive Cell Therapy
Juan José Soto-Castillo, Lucía Llavata-Marti, Roser Fort-Culillas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 22, 2004
Conditionally replicative adenovirus with tropism expanded towards integrins inhibits osteosarcoma tumor growth in vitro and in vivo
Adhiambo M Witlox, Victor W Van Beusechem, Bonnie Molenaar, et al.
Page
of 10